Techtronic Industries Co., Ltd. is an investment holding company, which engages in the manufacture and trade of electrical and electronic products. It operates through the Power Equipment, and ...

Tvardi Therapeutics recently announced preliminary results from its Phase 2 REVERT trial in idiopathic pulmonary fibrosis, revealing that TTI-101 did not show a significant difference in efficacy ...

One item to point out is that Tvardi Therapeutics (NASDAQ:TVRD) brought its pipeline forth to public trading because of a merger it enacted with Cara Therapeutics and thus was able to list on the ...

Rare-earth and lithium stocks rallied Monday after JPMorgan Chase & Co. announced a $1.5 trillion initiative to finance and invest in industries it believes are “critical to national economic security ...

Tvardi Therapeutics shares were 30% lower, at $7.19, in premarket trading after the company said its phase 2 study for TTI-101 didn't meet its goals. TTI-101 is a small molecule therapy targeting ...

Tvardi Therapeutics has failed its first big test as a public company. Months after joining the Nasdaq, the biotech has reported the unappetizing mix of high dropout rates and placebolike efficacy in ...

Thinking about what to do next with Techtronic Industries stock? You are not alone. Whether you are considering your first buy-in, thinking about holding through the latest ups and downs, or wondering ...

A California-based nuclear startup with roots in space exploration is headed to Oak Ridge. With a $280 million investment in East Tennessee, Radiant Industries aims to be the first to bring a portable ...

MANILA, Philippines — Malacañang has approved a long-term plan that seeks to support the country’s creative industries, a sector that employs more than seven million Filipinos. The Philippine Creative ...

TETRA Technologies has surged nearly 86% from my buy rating a year ago, and its valuation now appears stretched relative to industry peers. TTI's forward P/E ratio of 31 far exceeds Halliburton and ...